HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Emergency coronary angioplasty in refractory unstable angina.

Abstract
We performed percutaneous transluminal coronary angioplasty as an emergency procedure in 60 patients with unstable angina pectoris that was refractory to treatment with maximally tolerated doses of beta-blockers, calcium antagonists, and intravenous nitroglycerin. The initial success rate for angioplasty was 93 per cent (56 patients). There were no deaths related to the procedure, although total occlusion occurred in four patients. Despite emergency bypass grafting, all four sustained a myocardial infarction. All the patients were followed for at least six months. Late cardiac death occurred in one patient, whereas eight had recurrent angina pectoris. There was no progression to myocardial infarction. The restenosis rate was 28 per cent (13 of 46) in the patients with initially successful coronary angioplasty who had repeat angiography. Improved cardiac functional status after sustained successful coronary angioplasty was demonstrated by an almost normal capacity on bicycle exercise testing and the absence of ischemia during thallium isotope studies in 80 per cent. We conclude that emergency percutaneous transluminal coronary angioplasty may be useful for the treatment of selected patients with unstable angina pectoris who are unresponsive to intensive pharmacologic treatment.
AuthorsP J de Feyter, P W Serruys, M van den Brand, K Balakumaran, B Mochtar, A L Soward, A E Arnold, P G Hugenholtz
JournalThe New England journal of medicine (N Engl J Med) Vol. 313 Issue 6 Pg. 342-6 (Aug 08 1985) ISSN: 0028-4793 [Print] United States
PMID3159964 (Publication Type: Journal Article)
Topics
  • Adult
  • Aged
  • Angina Pectoris (therapy)
  • Angina, Unstable (therapy)
  • Angioplasty, Balloon (methods)
  • Coronary Vessels
  • Electrocardiography
  • Emergencies
  • Evaluation Studies as Topic
  • Exercise Test
  • Female
  • Follow-Up Studies
  • Humans
  • Male
  • Middle Aged
  • Myocardial Infarction (prevention & control)
  • Recurrence

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: